Last reviewed · How we verify
NCT05115058
A New Successful Approach for Emmetropic Presbyopic Patients Using Intrastromal Pocket With Smile Module
NA trial testing relex Smile module in Presbyopia in 41 participants. Status unknown.
1 June 2018
Quick facts
| Lead sponsor | Eye Hospital Pristina Kosovo |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 41 |
| Start date | 1 June 2016 |
| Primary completion | 1 June 2018 |
| Estimated completion | 1 September 2024 |
| Sites | 1 location across Kosovo |
Drugs / interventions tested
- relex Smile module
Conditions studied
- Presbyopia — all drugs for Presbyopia →
Sponsor
Eye Hospital Pristina Kosovo
Who can join
Adults 40 to 50, any sex, with Presbyopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Presbyopia is physiological insufficiency of accommodation associated with the aging of the eye that results in progressively worsening ability to focus clearly on close objects.Though presbyopia is a normal change in our eyes as we age, it often is a significant and emotional event because it's a sign of aging that's impossible to ignore and difficult to hide. This defect is usually corrected by using glasses with bifocal power of suitable focal lengths. But some patients don't want to use glasses for correction. In our study purpose is to show that near vision improves and patient satisfaction increases by preparing an intrastromal pocket for emmetropic patients with near vision problems using the SMILE module.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05115058
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Presbyopia
Currently open trials in the same condition.
- NCT07444658 — Performance of Two Daily Disposable Multifocal Contact Lenses · NA · recruiting
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07077967 — Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs · recruiting
- NCT07113210 — Quality of Life in Presbyopic Patients Who Are Treated With Qlosi · Phase 4 · recruiting
- NCT06948357 — Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients · Phase 2 · recruiting
Other Eye Hospital Pristina Kosovo trials
Trials by the same sponsor.
- NCT04642729 — Fresh Corneal Lenticule Implantation in Macular Corneal Distrophy With Relex Smile Surgery · NA · unknown
- NCT04594512 — Fresh Corneal Lenticule Implantation and Autologous Serum - Case Report · NA · active not recruiting
- NCT04616144 — Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism · NA · active not recruiting
- NCT04793893 — Treatment of Residual Hypermetropic Refraction on Young Patients After LASIK Using Human Fresh Corneal Lenticule Implant · NA · unknown
- NCT04468022 — Toric Trifocal IOL Treatment With High Astigmatism and Hyperopia vs SMILE Enhancement After Trifocal IOL Treatment · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05115058 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eye Hospital Pristina Kosovo
- Last refreshed: 20 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05115058.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing